天津市抗骨质疏松治疗与药物相关性颌骨坏死问题的专家共识

Expert consensus on anti-osteoporosis therapy and medication-related jaw necrosis in Tianjin

骨质疏松症(OP)和口腔疾患是老年人常见的健康问题,近年来OP治疗药物相关的颌骨坏死风险日益受到相关专业医生的关注。在OP治疗前和治疗中为避免或减少药物相关性颌骨坏死的发生,需要妥善处理口腔有创性操作与OP治疗间的关系。由天津市医学会骨质疏松和骨矿盐疾病分会、天津市口腔医学会口腔颌面外科专业委员会主持,经过从事OP治疗的医生和口腔专业医生的充分交流和沟通,在循证医学基础上达成临床共识,即明确了OP和OP治疗药物相关性颌骨坏死均是具有严重不良后果的疾病,规范OP治疗可减少骨折,有利于改善老年人生活质量;在治疗期间应采取恰当措施,尽可能避免OP治疗药物相关性颌骨坏死的发生。通过两个学科医生的共同努力,以期解决由于使用OP治疗药物而影响口腔操作的临床难题,促进和保障老年人的骨骼健康和牙齿健康。

Osteoporosis(OP)and oral diseases are common health problems of the elderly.Recently,the risk of jaw necrosis with anti-OP medication has been increasingly concerned by relevant specialists.In order to avoid or reduce the incidence of medication-related jaw necrosis before and during OP treatment,it is necessary to properly deal with the relationship between oral invasive procedures and anti-OP treatment.It is conducted by the Osteoporosis and Bone Mineral Salt Disease Branch of Tianjin Medical Association and Society of Oral and Maxillofacial Surgery of Tianjin Stomatological Association.After full exchange and communication between doctors engaged in OP treatment and stomatological doctors,clinical consensus are reached on the basis of evidence-based medicine.It is clear that OP and OP medication-related necrosis of jaw are both diseases with serious adverse consequences,and standard OP treatment can reduce fractures and improve the quality of life of elderly.During the treatment period,appropriate measures should be taken to avoid the occurrence of OP medication-related jaw necrosis.Through the joint efforts of doctors from the two disciplines,we hope to solve clinical problems that affect oral operation due to the use of OP therapeutic drugs,and promote and protect the bone health and dental health of elderly.